AdaptHealth closed at $7.31 on Nov 4, up 16.40%, 45.4% below its 52-week closing high. Volume of 6.3M shares was 2.62× its 20-day average (well above normal).
Split-adjusted performance: +26.7% over one month, -36.0% over six months, -19.6% over one year.
In the quarter ended Jun 30, 2026, revenue was $740.31M, up 12.7% from a year earlier, with a net margin of -18.1%.
Short interest was 10.2M shares at the Oct 15 settlement, up 6.7% from the prior report (11.5% of float, 4.7 days to cover).